Optimizing vaccine development.

Optimizing vaccine development.

Item
http://www.wikidata.org/entity/Q37883493
Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approachInCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunityMucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccineMgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection.Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines.The use of plants for the production of therapeutic human peptides.Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.Vaccine strategies against cystic fibrosis pathogens.Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults
P2860

Optimizing vaccine development.

Item
http://www.wikidata.org/entity/Q37883493
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimizing vaccine development.
@en
Optimizing vaccine development.
@nl
type
label
Optimizing vaccine development.
@en
Optimizing vaccine development.
@nl
prefLabel
Optimizing vaccine development.
@en
Optimizing vaccine development.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Optimizing vaccine development.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1462-5822.2011.01609.X
P433
P478
P50
P577
P5875
P698